MW 305.4 Da, Purity >98%. Vanilloid receptor (VR1) agonist (pEC50 values are 7.5 and 6.1 at human and rat VR1 receptors, respectively). Antinociceptive and anti-inflammatory effects mediated by primary afferent sensory neurones. Induces reversible inhibition of platelet aggregation.
MW 305.4 Da, Purity >98%. Vanilloid receptor (VR1) agonist (pEC50 values are 7.5 and 6.1 at human and rat VR1 receptors, respectively). Antinociceptive and anti-inflammatory effects mediated by primary afferent sensory neurones. Induces reversible inhibition of platelet aggregation.
Soluble in DMSO to 50 mM.
Soluble in ethanol to 50 mM.
Vanilloid receptor (VR1) agonist (pEC50 values are 7.5 and 6.1 at human and rat VR1 receptors, respectively). Antinociceptive and anti-inflammatory effects mediated by primary afferent sensory neurones. Induces reversible inhibition of platelet aggregation.
This product is manufactured by BioVision, an Abcam company and was previously called 2521 Capsaicin. 2521-250 is the same size as the 250 mg size of ab141000.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab141000, (E)-Capsaicin, Vanilloid receptor agonist
Capsaicin induces Ca2+ influx via activation of TRPV1 channels expressed in C6 cells. Cells were loaded with Fluo-3 AM (Fluo-3 AM, Fluorescent calcium Indicator ab145254) and stimulated with Capsaicin (ab141000). Changes in intracellular Ca2+ were detected via changes in Fluo-3 emission following application. The left panel shows normalized fluorescence before and after application (at 20 seconds) of 0-10 µM Capsaicin (as indicated). The right panel shows normalized fluorescence plotted against Capsaicin concentrations.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com